Incidence and clinical spectrum of rhabdomyolysis in neurology: a retrospective cohort study

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

[1]  N. Voermans,et al.  The etiology of rhabdomyolysis: an interaction between genetic susceptibility and external triggers , 2020, European journal of neurology.

[2]  Kristen M. Laricchia,et al.  Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness , 2020, Genetics in Medicine.

[3]  J. Sejvar,et al.  Neurological associations of COVID-19 , 2020, The Lancet Neurology.

[4]  B. Schoser,et al.  A systematic review on the definition of rhabdomyolysis , 2019, Journal of Neurology.

[5]  G. Lippi,et al.  Diagnostic biomarkers of muscle injury and exertional rhabdomyolysis , 2018, Clinical chemistry and laboratory medicine.

[6]  Z. Shi,et al.  Muscle damage in patients with neuromyelitis optica spectrum disorder , 2017, Neurology: Neuroimmunology & Neuroinflammation.

[7]  F. Leutmezer,et al.  Epidemiology of Multiple Sclerosis in Austria , 2017, Neuroepidemiology.

[8]  P. Laforêt,et al.  Exertional rhabdomyolysis: physiological response or manifestation of an underlying myopathy? , 2016, BMJ Open Sport & Exercise Medicine.

[9]  J. Frederiksen,et al.  Rhabdomyolysis following interferon-beta treatment in a patient with multiple sclerosis - A case report. , 2016, Multiple sclerosis and related disorders.

[10]  J. Varon,et al.  Beyond muscle destruction: a systematic review of rhabdomyolysis for clinical practice , 2016, Critical Care.

[11]  L. Crofford,et al.  Causes of creatine kinase levels greater than 1000 IU/L in patients referred to rheumatology , 2016, Clinical Rheumatology.

[12]  Jeroen S. de Bruin,et al.  Clinical decision support systems at the Vienna General Hospital using Arden Syntax: Design, implementation, and integration , 2015, Artif. Intell. Medicine.

[13]  A. Mammen,et al.  Diagnostic evaluation of rhabdomyolysis , 2015, Muscle & nerve.

[14]  F. Zimprich,et al.  Epidemiology of Amyotrophic Lateral Sclerosis and Effect of Riluzole on Disease Course , 2015, Neuroepidemiology.

[15]  Sushrut S Waikar,et al.  A risk prediction score for kidney failure or mortality in rhabdomyolysis. , 2013, JAMA internal medicine.

[16]  R. Quinlivan,et al.  Myopathic causes of exercise intolerance with rhabdomyolysis , 2012, Developmental medicine and child neurology.

[17]  C. Angelini,et al.  EFNS guidelines on the diagnostic approach to pauci‐ or asymptomatic hyperCKemia , 2010, European journal of neurology.

[18]  E. Poch,et al.  Rhabdomyolysis and acute kidney injury. , 2009, The New England journal of medicine.

[19]  M. Rosner,et al.  Acute kidney injury. , 2009, Current drug targets.

[20]  G. Melli,et al.  Rhabdomyolysis: An Evaluation of 475 Hospitalized Patients , 2005, Medicine.

[21]  P. Toft,et al.  Prognostic value, kinetics and effect of CVVHDF on serum of the myoglobin and creatine kinase in critically ill patients with rhabdomyolysis , 2005, Acta anaesthesiologica Scandinavica.

[22]  Joseph Varon,et al.  Bench-to-bedside review: Rhabdomyolysis – an overview for clinicians , 2004, Critical care.

[23]  P. Schmitz,et al.  Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain‐Barré syndrome , 1991, Muscle & nerve.

[24]  M. Ward.  Factors predictive of acute renal failure in rhabdomyolysis. , 1988, Archives of internal medicine.

[25]  E. Wyllie,et al.  Postictal serum creatine kinase in the diagnosis of seizure disorders. , 1985, Archives of neurology.

[26]  P. Gabow,et al.  The Spectrum of Rhabdomyolysis , 1982, Medicine.

[27]  J. Walton,et al.  Serum-creatine-kinase in cases of stroke, head injury, and meningitis. , 1967, Lancet.

[28]  L. Bongiovanni,et al.  Postictal serum creatine kinase for the differential diagnosis of epileptic seizures and psychogenic non-epileptic seizures: a systematic review , 2014, Journal of Neurology.

[29]  T. Ohwada,et al.  Rapid fall in blood myoglobin in massive rhabdomyolysis and acute renal failure , 2005, Intensive Care Medicine.

[30]  J. Veenstra,et al.  Relationship between elevated creatine phosphokinase and the clinical spectrum of rhabdomyolysis. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.